| 1 |
34643088 | GALNT14 regulates ferroptosis and apoptosis of ovarian cancer through the EGFR/mTOR pathway. | 2022 Jan |
1 |
| 2 |
35001804 | Protein tyrosine phosphatase receptor type Z1 inhibits the cisplatin resistance of ovarian cancer by regulating PI3K/AKT/mTOR signal pathway. | 2022 Jan |
1 |
| 3 |
35057550 | Olive Mill Wastewater Inhibits Growth and Proliferation of Cisplatin- and Gemcitabine-Resistant Bladder Cancer Cells In Vitro by Down-Regulating the Akt/mTOR-Signaling Pathway. | 2022 Jan 15 |
1 |
| 4 |
35238281 | BEZ235 reduction of cisplatin resistance on wild-type EGFR non-small cell lung cancer cells. | 2022 Mar 3 |
3 |
| 5 |
35263216 | Circular RNA UBAP2 facilitates the cisplatin resistance of triple-negative breast cancer via microRNA-300/anti-silencing function 1B histone chaperone/PI3K/AKT/mTOR axis. | 2022 Mar |
2 |
| 6 |
33073679 | mTOR Inhibition Ablates Cisplatin-Resistant Salivary Gland Cancer Stem Cells. | 2021 Apr |
5 |
| 7 |
33179318 | Pseudogene KRT17P3 drives cisplatin resistance of human NSCLC cells by modulating miR-497-5p/mTOR. | 2021 Jan |
2 |
| 8 |
33568627 | BCAT1 decreases the sensitivity of cancer cells to cisplatin by regulating mTOR-mediated autophagy via branched-chain amino acid metabolism. | 2021 Feb 10 |
5 |
| 9 |
33575476 | Metformin enhances anti-cancer effects of cisplatin in meningioma through AMPK-mTOR signaling pathways. | 2021 Mar 26 |
2 |
| 10 |
33717260 | The miR-136-5p/ROCK1 axis suppresses invasion and migration, and enhances cisplatin sensitivity in head and neck cancer cells. | 2021 Apr |
1 |
| 11 |
33846781 | Metformin impairs cisplatin resistance effects in A549 lung cancer cells through mTOR signaling and other metabolic pathways. | 2021 Jun |
1 |
| 12 |
33908630 | Cyanidin-3-O-glucoside and cisplatin inhibit proliferation and downregulate the PI3K/AKT/mTOR pathway in cervical cancer cells. | 2021 Jun |
1 |
| 13 |
34046349 | Down-Regulating the Expression of miRNA-21 Inhibits the Glucose Metabolism of A549/DDP Cells and Promotes Cell Death Through the PI3K/AKT/mTOR/HIF-1α Pathway. | 2021 |
2 |
| 14 |
34077013 | Apatinib strengthens the anti-tumor effect of cisplatin in thyroid carcinoma through downregulating VEGFR2. | 2021 Mar-Apr |
4 |
| 15 |
34077027 | Tormentic acid induces anticancer effects in cisplatin-resistant human cervical cancer cells mediated via cell cycle arrest, ROS production, and targeting mTOR/PI3K/AKT signalling pathway. | 2021 Mar-Apr |
2 |
| 16 |
34261004 | Cisplatin's potential for type 2 diabetes repositioning by inhibiting CDKN1A, FAS, and SESN1. | 2021 Aug |
1 |
| 17 |
34277781 | A novel peptide promotes human trophoblast proliferation and migration through PI3K/Akt/mTOR signaling pathway. | 2021 Jun |
2 |
| 18 |
34298686 | Deregulation of Exo70 Facilitates Innate and Acquired Cisplatin Resistance in Epithelial Ovarian Cancer by Promoting Cisplatin Efflux. | 2021 Jul 11 |
1 |
| 19 |
34329824 | Improved tumor-suppressive effect of OZ-001 combined with cisplatin mediated by mTOR/p70S6K and STAT3 inactivation in A549 human lung cancer cells. | 2021 Oct |
4 |
| 20 |
34427099 | HDAC3-mediated lncRNA-LOC101928316 contributes to cisplatin resistance in gastric cancer via activating the PI3K-Akt-mTOR pathway. | 2021 Sep |
2 |
| 21 |
34543857 | STAT3 contributes to cisplatin resistance, modulating EMT markers, and the mTOR signaling in lung adenocarcinoma. | 2021 Sep 17 |
5 |
| 22 |
34876569 | TTK inhibition increases cisplatin sensitivity in high-grade serous ovarian carcinoma through the mTOR/autophagy pathway. | 2021 Dec 7 |
5 |
| 23 |
34915755 | A nano based approach to alleviate cisplatin induced nephrotoxicity. | 2021 Jan-Dec |
1 |
| 24 |
31267531 | microRNA-10b confers cisplatin resistance by activating AKT/mTOR/P70S6K signaling via targeting PPARγ in esophageal cancer. | 2020 Feb |
2 |
| 25 |
31558183 | Overexpression of the Long Noncoding RNA FOXD2-AS1 Promotes Cisplatin Resistance in Esophageal Squamous Cell Carcinoma Through the miR-195/Akt/mTOR Axis. | 2020 Feb 7 |
3 |
| 26 |
31843707 | Curcumin attenuates cognitive impairment by enhancing autophagy in chemotherapy. | 2020 Mar |
1 |
| 27 |
31913198 | miR-21 modulates cisplatin resistance of gastric cancer cells by inhibiting autophagy via the PI3K/Akt/mTOR pathway. | 2020 Apr |
3 |
| 28 |
31917287 | TIPE2 suppressed cisplatin resistance by inducing autophagy via mTOR signalling pathway. | 2020 Apr |
2 |
| 29 |
32097729 | ROS enhances the cytotoxicity of cisplatin by inducing apoptosis and autophagy in tongue squamous cell carcinoma cells. | 2020 May |
2 |
| 30 |
32104214 | Ghrelin inhibits cisplatin-induced MDA-MB-231 breast cancer cell apoptosis via PI3K/Akt/mTOR signaling. | 2020 Mar |
3 |
| 31 |
32131519 | Unique Triterpenoid of Jujube Root Protects Cisplatin-induced Damage in Kidney Epithelial LLC-PK1 Cells via Autophagy Regulation. | 2020 Mar 2 |
2 |
| 32 |
32267053 | Salicylate sensitizes oral squamous cell carcinoma to chemotherapy through targeting mTOR pathway. | 2020 Apr 8 |
1 |
| 33 |
32277616 | Tormentic acid induces anticancer effects in cisplatin-resistant human cervical cancer cells mediated via cell cycle arrest, ROS production, and targeting mTOR/PI3K/AKT signalling pathway. | 2020 Jan-Feb |
2 |
| 34 |
32308804 | Plumbagin Enhances the Anticancer Efficacy of Cisplatin by Increasing Intracellular ROS in Human Tongue Squamous Cell Carcinoma. | 2020 |
1 |
| 35 |
32323781 | MicroRNA‑22 mediates the cisplatin resistance of osteosarcoma cells by inhibiting autophagy via the PI3K/Akt/mTOR pathway. | 2020 Apr |
9 |
| 36 |
32368441 | The inhibition of MARK2 suppresses cisplatin resistance of osteosarcoma stem cells by regulating DNA damage and repair. | 2020 Aug |
2 |
| 37 |
32458975 | SIK2 Promotes Cisplatin Resistance Induced by Aerobic Glycolysis in Breast Cancer Cells through PI3K/AKT/mTOR Signaling Pathway. | 2020 May 27 |
3 |
| 38 |
32593915 | Testicular cancer: Determinants of cisplatin sensitivity and novel therapeutic opportunities. | 2020 Aug |
1 |
| 39 |
32599072 | Role of mTOR As an Essential Kinase in SCLC. | 2020 Sep |
1 |
| 40 |
32608202 | Synergistic Antitumor Effects of Combined Treatment with HSP90 Inhibitor and PI3K/mTOR Dual Inhibitor in Cisplatin-Resistant Human Bladder Cancer Cells. | 2020 Jul |
3 |
| 41 |
32744675 | MiR-100 up-regulation enhanced cell autophagy and apoptosis induced by cisplatin in osteosarcoma by targeting mTOR. | 2020 Jul |
1 |
| 42 |
32800561 | Baicalein enhanced cisplatin sensitivity of gastric cancer cells by inducing cell apoptosis and autophagy via Akt/mTOR and Nrf2/Keap 1 pathway. | 2020 Oct 20 |
1 |
| 43 |
32819590 | GDC-0980 (apitolisib) treatment with gemcitabine and/or cisplatin synergistically reduces cholangiocarcinoma cell growth by suppressing the PI3K/Akt/mTOR pathway. | 2020 Sep 3 |
1 |
| 44 |
33112540 | Effect of Combined Sorafenib/Cisplatinum Treatment on the Autophagy and Proliferation of Hepatocellular Carcinoma hepG2 Cells in Vitro. | 2020 Oct 1 |
2 |
| 45 |
33115978 | Long Noncoding RNA HOXA11-AS Modulates the Resistance of Nasopharyngeal Carcinoma Cells to Cisplatin via miR-454-3p/c-Met. | 2020 Oct 31 |
1 |
| 46 |
33123242 | Synergistic antitumor effect of dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with cisplatin on drug-resistant non-small cell lung cancer cell. | 2020 Dec |
1 |
| 47 |
33275201 | Regulation of mTOR by miR-107 to facilitate glioma cell apoptosis and to enhance cisplatin sensitivity. | 2020 Nov |
1 |
| 48 |
33362566 | Berberine Improves Chemo-Sensitivity to Cisplatin by Enhancing Cell Apoptosis and Repressing PI3K/AKT/mTOR Signaling Pathway in Gastric Cancer. | 2020 |
2 |
| 49 |
33391038 | AMPK/mTOR Signaling in Autophagy Regulation During Cisplatin-Induced Acute Kidney Injury. | 2020 |
3 |
| 50 |
30144378 | ADP sensitizes ZL55 cells to the activity of cisplatin. | 2019 Apr |
3 |